Initiator Pharma A/S Initiator Pharma A/S

Initiator Pharma A/S

INIT

Rank in Stocks #27190
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to... Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.23069763
Last synced: 2026-11-12
Market Cap
$15.79M
Change (1 day)
-8.56%
Change (1 year)
-21.37%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Category

Healthcare
P/E ratio for Initiator Pharma A/S (INIT)
P/E ratio as of November 2026 TTM: -3.80
According to Initiator Pharma A/S's latest financial reports and stock price, its current price-to-earnings ratio (TTM) is -3.80. At the end of 2025 the company had a P/E ratio of -8.88.
P/E ratio history for Initiator Pharma A/S from 2016 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -3.80 -57.24%
2025 -8.88 -53.65%
2024 -19.16 -99.86%
2023 -14.14K 277,318,398.04%
2022 -0.01 -47.96%
2021 -0.01 -12.50%
2020 -0.01 -32.53%
2019 -0.02 260.87%
2018 0.00 187.50%
2017 0.00 -100.00%
2016 -47.23 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
-8.15 114.52%
US
34.39 -1,005.73%
US
-31.59 732.01%
US
-25.99 584.31%
AU
25.67 -776.03%
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.

Questions about Initiator Pharma A/S's P/E ratio

What is Initiator Pharma A/S's P/E ratio?

Initiator Pharma A/S's P/E ratio is -3.80, as of Nov 2026.

What was Initiator Pharma A/S's P/E ratio in 2025?

In 2025, Initiator Pharma A/S's P/E ratio was -8.88, compared with -19.16 in 2024.

How has Initiator Pharma A/S's P/E ratio changed since 2020?

From 2020 to 2025, Initiator Pharma A/S's P/E ratio was highest in 2022 (-0.01) and lowest in 2023 (-14.14K).

How does Initiator Pharma A/S's P/E ratio compare with similar companies?

Initiator Pharma A/S's P/E ratio (-3.80) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 34.39.